Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill …

M Gatti, PG Cojutti, F Pea - Critical Care, 2024 - Springer
To perform a systematic review with meta-analysis with the dual intent of assessing the
impact of attaining aggressive vs. conservative beta-lactams PK/PD target on the clinical …

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - Antibiotics, 2024 - mdpi.com
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …